Global X Japan’s Royalty Pharma RPRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$10.6K Sell
182
-234
-56% -$13.8K ﹤0.01% 354
2026
Q2
$23.3K Sell
416
-52
-11% -$2.71K ﹤0.01% 278
2026
Q1
$22.4K Sell
468
-90
-16% -$3.94K ﹤0.01% 257
2025
Q4
$21.6K Buy
558
+129
+30% +$4.92K ﹤0.01% 226
2025
Q3
$15.1K Sell
429
-145
-25% -$5.25K ﹤0.01% 261
2025
Q2
$20.7K Buy
574
+160
+39% +$5.3K ﹤0.01% 199
2025
Q1
$12.9K Sell
414
-45
-10% -$1.43K ﹤0.01% 255
2024
Q4
$11.7K Buy
459
+99
+28% +$2.62K ﹤0.01% 245
2024
Q3
$10.2K Buy
+360
New +$10K ﹤0.01% 266

Other funds holding RPRX

Global X Japan's RPRX Position: Q3 2026 in Review

Global X Japan reduced its Royalty Pharma (RPRX) stake by 56% in Q3 2026, selling an estimated $13.8K and leaving 182 shares worth $10.6K. The position accounts for ﹤0.01% of the portfolio, ranked #354.

Global X Japan first reported a position in RPRX in Q3 2024 and has held it in 9 quarters since. The position peaked at $23.3K in Q2 2026. 573 funds tracked by Wall St. Rank hold RPRX as of Q3 2026.

  • Global X Japan held 182 shares of Royalty Pharma worth $10.6K as of Q3 2026.
  • Global X Japan sold 234 Royalty Pharma shares in Q3 2026, an estimated $13.8K.
  • Royalty Pharma made up ﹤0.01% of Global X Japan's portfolio in Q3 2026, its #354 holding.
  • Global X Japan first reported a position in Royalty Pharma in Q3 2024 and has held it in 9 quarters since.
  • Global X Japan's Royalty Pharma position peaked at $23.3K in Q2 2026.
  • 573 funds tracked by Wall St. Rank held Royalty Pharma as of Q3 2026.

Based on Global X Japan's 13F filing for Q3 2026, filed 21 Oct 2026.